MMWR Recomm Rep. 2010 Dec 17;59(RR-12):1-110.

Sexually transmitted diseases treatment guidelines, 2010.

Workowski KA¹, Berman S; Centers for Disease Control and Prevention (CDC).

Collaborators (87)

Workowski KA, Bauer H, Bachman L, Burstein G, Eckert L, Geisler WM, Ghanem K, Golden M, Gorgos L, Hammerschlag M, Hollier L, Leone P, Marrazzo J, Mayer KH, Nyirjesy P, Rompalo A, Sanchez P, Stoner B, Wald A, Wendel G, Wiesenfeld HC, Cates W Jr, Holmes KK, Martin D, Handsfield H, McCormack W, Geisler WM, Adkinson NF, Andrews W, Augenbraun M, Batteiger B, Bolan G, Coles B, Deal C, Fortenberry JD, Hook E 3rd, Schwebke JR, Schulte J, Soper D, Stanberry L, Trigg B, Wimberly Y, Zenilman JM, Aaron K, Bachman L, Barclay L, Blythe MJ, Deal CD, Dimitrakov J, FitzGerald M, Fortenberry D, Hook EW 3rd, Jack N, Kerndt P, Marrazzo J, Ndowa FJ, Parkinson M, Piepert J, Reams P, Salhi B, Shea K, Soper D, Stoner B, Swann A, Tan L, Wong T, Workowski KA, Voigt R, Datta D, Dunne E, Hogben M, Holmberg S, Koumans E, Newman L, Aral SO, Ballard R, Branson B, Brooks J, Douglas J, Friedman A, Hu D, Kilmarx P, Papp J, Spradling P, Kelley B, Barner V, McElroy D.

Author information

1: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA 30333, USA. kgw2@cdc.gov

Erratum in

MMWR Recomm Rep. 2011 Jan 14;60(1):18. Dosage error in article text.

Abstract

These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 18-30, 2009. The information in this report updates the 2006 Guidelines for Treatment of Sexually Transmitted Diseases (MMWR 2006;55[No. RR-11]). Included in these updated guidelines is new information regarding 1) the expanded diagnostic evaluation for cervicitis and trichomoniasis; 2) new treatment recommendations for bacterial vaginosis and genital warts; 3) the clinical efficacy of azithromycin for chlamydial infections in pregnancy; 4) the role of Mycoplasma genitalium and trichomoniasis in urethritis/cervicitis and treatment-related implications; 5) lymphogranuloma venereum proctocolitis among men who have sex with men; 6) the criteria for spinal fluid examination to evaluate for neurosyphilis; 7) the emergence of azithromycin-resistant Treponema pallidum; 8) the increasing prevalence of antimicrobial-resistant Neisseria gonorrhoeae; 9) the sexual transmission of hepatitis C; 10) diagnostic evaluation after sexual assault; and 11) STD prevention approaches.